Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients
Liver International · 2024
DOI: 10.1111/liv.15919 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2024. Verfasst von Hannes Hegmar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Disease Progression, Liver Cirrhosis, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Background & Aims Liver stiffness measurement (LSM) by vibration‐controlled transient elastography (VCTE) is a non‐invasive diagnostic biomarker of liver fibrosis. It is uncertain if LSM can predict risk for future liver‐related outcomes in large, heterogenous populations.
Methods
This Swedish multi‐centre cohort study included patients ( n = 14 414) from 16 sites who underwent LSM by VCTE between 2008 and 2020. Outcomes were ascertained from national registers. We investigated progression to cirrhosis with portal hypertension or hepatocellular carcinoma (HCC), separately. Cox regression was used to obtain hazard ratios (HRs). Harrel's C‐index was used to measure discrimination of VCTE.
Results
Included patients had a median age of 46 (interquartile range 34–57), median LSM of 5.9 kPa (4.6–8.0), 59% were male, and the majority had hepatitis C (50.1%). During a median follow‐up of 5.9 (4.3–8.0) years, 402 patients (2.7%) developed cirrhosis with portal hypertension. In patients with an LSM ≥25 kPa, 28.7% developed cirrhosis with portal hypertension within 5 years of follow‐up, while only .6% of patients with an LSM
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Infectious Diseases, University Hospital of Umeå, Umeå, Sweden.
- Department of Infectious Diseases, Falun Hospital, Falun, Sweden.
- Department of Infectious Diseases, Sundsvall-Härnösand Regional Hospital, Sundsvall, Sweden.
ORCID-Profile: Hannes Hegmar, Axel Wester, Patrik Nasr, Hannes Hagström
Förderung
- Pfizer
Zitieren
APA
Hegmar, H., Wester, A., Aleman, S., Backman, J., Degerman, E., Ekvall, H., Lund, K., Lundgren, Å., Nasr, P., Shahnavaz, A., Vessby, J., Westin, J., Önnerhag, K., & Hagström, H. (2024). Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients. Liver International. https://doi.org/10.1111/liv.15919
Vancouver
Hegmar H, Wester A, Aleman S, Backman J, Degerman E, Ekvall H, et al. Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients. Liver International. 2024. doi:10.1111/liv.15919
BibTeX
@article{Hegmar2024,
author = {Hegmar, Hannes and Wester, Axel and Aleman, Soo and Backman, Jens and Degerman, Erik and Ekvall, Håkan and Lund, Katarina and Lundgren, Åsa and Nasr, Patrik and Shahnavaz, Afshin and Vessby, Johan and Westin, Johan and Önnerhag, Kristina and Hagström, Hannes},
title = {Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15919}
}
EUVIMED